Former leaders, celebrities, and a Nobel Prize-winning scientist are urging Gilead Sciences to make HIV medicine Lenacapavir available globally to prevent a repeat of history where effective drugs were not accessible.
The drug, Lenacapavir, could be a gamechanger both for treating and preventing HIV, but its current high cost and limited availability in wealthy countries pose significant challenges for global accessibility.
#hiv-medicine #global-accessibility #healthcare-equity #pharmaceutical-company #unitaid-backed-medicines-patent-pool
Collection
[
|
...
]